CAS: 1246960-27-9 - 2-Piperazinone, 4-[(3R)-3-amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-3-[(1,1-dimethylethoxy)methyl]-, hydrochloride (1:1), (3R)-

Formule : C₁₉H₂₆F₃N₃O₃·ClH

InChI : InChI=1S/C19H26F3N3O3.ClH/c1-19(2,3)28-10-16-18(27)24-4-5-25(16)17(26)8-12(23)6-11-7-14(21)15(22)9-13(11)20;/h7,9,12,16H,4-6,8,10,23H2,1-3H3,(H,24,27);1H/t12-,16-;/m1./s1

Code InChI : InChIKey=QHQXWMKKQNSBTC-VQZRABBESA-N

SMILES : Cl.O=C1NCCN(C(=O)CC(N)CC2=CC(F)=C(F)C=C2F)C1COC(C)(C)C

Synonymes :

• 2-Piperazinone, 4-[(3R)-3-amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-3-[(1,1-dimethylethoxy)methyl]-, hydrochloride (1:1), (3R)-

Evogliptin HCl

CAS : 1246960-27-9

Evogliptin (DA-1229), a DPP4 inhibitor, enhances insulin sensitivity and delays diabetes onset.

• Formule : C₁₉H₂₇ClF₃N₃O₃
• Couleur et forme : Solid
• Masse moléculaire : 437.88